Oslounivsykehus
Oslo University Hospital (OUS) is Scandinavia’s largest and one of Europe’s leading university hospitals, employing over 24,000 staff across more than 40 locations in Oslo and has a budget of 23 billion NOK. Formed by merging Aker, Rikshospitalet, and Ullevål University Hospitals, it serves as the primary provider of advanced patient care, emergency services, and specialist treatments for Oslo, the region, and the nation. The hospital is responsible for around half of all medical research conducted at Norwegian hospitals and plays a central role in educating healthcare professionals. Closely affiliated with the University of Oslo, Oslo University Hospital is internationally recognized for its pioneering research, innovation, and comprehensive healthcare services, treating more than 1.2 million patients annually and continually investing in modern facilities to meet future healthcare needs.
Role within SCALPEL
Oslo University Hospital (OUS) leads the groundbreaking SCALPEL project, a European initiative redefining cancer treatment through innovative photoimmunotherapy. As project coordinator, OUS must ensure seamless collaboration across six European partners, manage funding distribution, and act as the primary liaison with the European Commission. Beyond administration, OUS drives critical research components:
Scientific leadership
- In vitro validation: Collaborating with Gustav Roussy Cancer Centre (GRCC), OUS tests light-activated antibodies’ precision in eliminating cancer cells, in vitro.
- In vivo proof-of-concept: Partnering with Slovenia’s National Institute of Chemistry (NIC), OUS evaluates the therapeutic efficacy of SCALPEL in advanced preclinical models.
Innovation to clinic The SCALPEL approach combines light-sensitive antibodies that “click” to cancer cells for surgical precision, aiming to establish drug-free remission and long-term immunity. OUS works with EURICE to strategically disseminate breakthroughs while safeguarding intellectual property, and accelerating the path to the clinic.

